| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Inson Paul Joseph | Chief People Officer | C/O IBEX LIMITED, 1717 PENNSYLVANIA AVENUE NW, SUITE 825, WASHINGTON | Lisa Lenstrohm, Attorney-in-Fact | 02 Oct 2025 | 0001974089 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IBEX | Common Shares | Award | $0 | +2,347 | +72% | $0.000000 | 5,613 | 30 Sep 2025 | Direct | F1 |
| transaction | IBEX | Common Shares | Sale | $27,588 | -697 | -12% | $39.58 | 4,916 | 02 Oct 2025 | Direct | F2, F3 |
| Id | Content |
|---|---|
| F1 | On September 30, 2025, 2,347 performance-based stock units ("PSUs") were earned and acquired by the Reporting Person. These PSUs were earned upon certification of performance goals for the period ending June 30, 2025 and converted to Common shares. |
| F2 | The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based stock units and do not represent discretionary trades by the Reporting Person. |
| F3 | This transaction was executed in multiple trades at prices ranging from $39.34 to $40.01; the price reported above reflects the weighted average sales price. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |